You are here

An Update on Activated Protein C (Xigris) In the Management of Sepsis

Cesar Alaniz, PharmD
PDF version: 
Although human activated protein C (APC) has been used for years in patients with severe sepsis, trials have shown a lack of efficacy for the product and an increased incidence of bleeding. As a result, further study is needed to determine which patients are appropriate candidates for APC therapy.